Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Healthy to Inflamed Pouch FMT for Chronic Pouchitis
NCT05829109Phase 1Recruiting
- Sponsor
- MAIA Biotechnology
- Start
- Oct 2024
- Primary completion
- Jun 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fecal microbiome transplant in pouchitis, sponsored by MAIA Biotechnology. Primary endpoint: Number of patients with FMT related adverse events at 8 weeks. Started Oct 2024; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT05829109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05829109.